NVAX FY 2016 Earnings — Novavax, Inc. Revenue & Financial Results | Market Cap Arena

NVAXNovavax, Inc.

$2B

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$15M-57.6% YoY

Gross Profit

-$223M-1449.8% margin

Operating Income

-$269M-1752.8% margin

Net Income

-$280M-1823.5% margin

EPS (Diluted)

$-20.68

Cash Flow

Operating Cash Flow

-$255M

Free Cash Flow

-$274M

Stock-Based Comp.

$19M

Balance Sheet

Total Assets

$394M

Total Liabilities

$400M

Stockholders' Equity

-$6M

Cash & Equivalents

$144M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15M	$36M	-57.6%
Gross Profit	-$223M	-$126M	-76.1%
Operating Income	-$269M	-$157M	-71.2%
Net Income	-$280M	-$157M	-78.4%